Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2020

May 11, 2020

SELL
$26.15 - $77.24 $326,875 - $965,499
-12,500 Closed
0 $0
Q4 2019

Jan 15, 2020

BUY
$60.18 - $154.77 $752,250 - $1.93 Million
12,500 New
12,500 $17,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $323M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Gainplan LLC Portfolio

Follow Gainplan LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gainplan LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gainplan LLC with notifications on news.